Serina Therapeutics, Inc. (SER) NYSE

5.63

-0.1153(-2.01%)

Updated at May 09 03:35PM

Currency In USD

Valuation

Market Cap36.87M
Enterprise Value33.46M
P/E Ratio-8.81
PEG Ratio-0.18
Price/Sales Ratio985.67
Price/Book Ratio76.47
Enterprise/Revenue924.88
Enterprise/EBITDA-10.23

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-99.34
Operating Margin-304.43

Management Effectiveness

Return On Assets-0.83
Return On Equity0.66

Income Statement

Revenue56,000
Revenue/Share0.01
Gross Profit-138,000
EBITDA-10.49M
Net Income-11.14M
Diluted EPS-1.51

Balance Sheet

Total Cash3.67M
Total Cash/Share0.41
Total Debt268,000
Total Debt/Equity0.42
Current Ratio2.4
Book Value Per Share0.06

Price History

52-Week Change-37.07
52-Week High14.57
52-Week Low3.81
Moving Average 50 Days5.11
Moving Average 200 Days5.96

Statistics

Average Volume10,924
Shares Outstanding9.97M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor7:250
Last Split DateMarch 15, 2024